Prednisolone Articles
Four drugmakers to pay $124 million for submission of false claims to USA’s Medicaid
20 October 2009
Sanofi-Aventis’ latest shopping spree includes France’s Fovea and deal with Merrimack
1 October 2009
Chugai/Roche to up Tamiflu supplies to Japan threefold
8 September 2009
Troubled outlook for future, reports Alizyme
29 May 2009
Japan stock market week to May 25, 2009
27 May 2009
"Antedrugs," a safer approach to therapy
20 April 2009
Alizyme's 2008 loss narrows 67% to $14.6M
30 March 2009
Four Novartis drugs and B-MS
9 March 2009
OctoPlus signs contract with Galapagos
16 February 2009
Lethal paracetamol hits Nigerian market
26 January 2009
Ono's interim results hit by NHI price cuts
8 December 2008
CombinatoRx' Synavive disappoints in Ph II trial
13 October 2008
Alizyme's first-half 2008 net loss narrows 28%
15 September 2008
Stock Commentary - Europe - week to Sept 1, 2008
8 September 2008
Call for AIDS "syrups" from MSF
1 September 2008
Japan stock market week to Aug 11, 2008
18 August 2008
Satraplatin European MAA withdrawn
11 August 2008
Alizyme
4 August 2008
217 drugs moved to OTC status in France
7 July 2008
Pediatric drug patent denied in India
30 June 2008
Taro gains final FDA appro for cetirizine
30 June 2008
Japan stock market week to May 26, 2008
2 June 2008
Galapagos licenses Enceladus RA drug
28 April 2008
CHMP advises labeling change for S-P
17 March 2008
Panama govt issues fake drug death tally
25 February 2008
Japan stock market week to Jan 28, 2008
4 February 2008
Roche's MabThera gets nod for EU label extension
24 December 2007
India's NPPA revises 164 product prices
24 December 2007
Alizyme and Prometheus sign UC drug deal
10 December 2007
US FDA approves new formulations of Zyrtec
26 November 2007
US study dismisses soft drink obesity link
3 September 2007
Japan stock market week to August 13, 2007
20 August 2007
BioMarin's 2nd-qtr 2007 loss widens to $3.9M
20 August 2007
US govt requests "rapid" drug action from China
6 August 2007
SFDA: "unsatisfactory" drug regulation in China
23 July 2007
Japan stock market week to May 28, 2007
4 June 2007
Chinese fake drug firm "not licensed"
14 May 2007
Evolutec's rEV131 fails in Ph II inflammation trial
15 January 2007
Evolutec completes recruitment in Ph II rEV131 trial
20 November 2006
34 killed in Panama by contaminated drugs
13 November 2006
Ranbaxy gets tentative approval for cetirizine syrup
13 November 2006
NICE approves MabThera as first-line therapy for NHL
2 October 2006
Japan stock market week to July 17, 2006
24 July 2006
UK's NICE calls for beta blocker phase out
3 July 2006
CRx-102 shows efficacy in osteoarthritis study
3 July 2006
UCB sells Delsym to Adams RT for $122M
5 June 2006
BioMarin and Alliant sign Orapred deal
27 March 2006
Child-friendly HIV/AIDS drugs call to industry
5 December 2005
BioMarin submist NDA to US FDA for ODT prednisolone
8 August 2005
Schering-Plough aims for 100B yen sales in Japan by 2010
18 April 2005
Hi-Tech licenses asthma drug from Biomarin
11 April 2005
India NPPA announces drug price revisions
11 April 2005
Stock Commentary - Europe
28 March 2005
Alizyme:'s Colal-Pred in ulcerative colitis
28 March 2005
South Africa awards ARV drug tenders
14 March 2005
Fujisawa makes strategic drug transfers ahead of merger
28 February 2005
Japan stock market week to February 21
28 February 2005
Roche's MabThera improves survival in NHL at 30 months
20 December 2004
BioMarin raises net loss 2004 forecast
4 October 2004
Taro Pharma gains FDA OK for generic loratadine syrup
30 August 2004
BioMarin sees 2nd-qtr loss rocket on Ascent acquisition
16 August 2004
Tokyo pharma stocks - week to August 9
16 August 2004
CHPA says cough/cold drugs are safe and effective
19 July 2004
MabThera on track for first-line use in NHL
5 July 2004
BioMarin completes Ascent acquisition
24 May 2004
Biomarin buys Medicis' pediatric unit for $175M
26 April 2004
New chewable Zyrtec cleared by FDA
29 March 2004
MabThera EU filing for first-line indolent NHL
26 January 2004
New data for Rituxan/ MabThera at ASH
15 December 2003
Aventis' Taxotere shows promise in early-stage breast cancer, filings expected 2004
15 December 2003
WHO steps up action against substandard and counterfeit medicines
24 November 2003
UK NICE recommends Roche's MabThera
29 September 2003
Stock Commentary - Tokyo
2 June 2003
Symbicort trial data for COPD and asthma
26 May 2003
India cuts malaria drug prices, raises others
14 April 2003
Taro Pharma 2nd qtr sales up 336%
29 July 2002
Ranbaxy set to launch Versed generic in USA
25 March 2002
Alizyme colitis drug clears Phase II trial
25 February 2002
CPMP backs new forms of S-P's desloratadine
14 January 2002
Unither to buy Coutances plant from Sanofi-Synthelabo
7 January 2002
Alizyme expects results from Phase II trial of Colal-Pred
7 January 2002
Alizyme expects results from Phase II trial of Colal-Pred
24 December 2001
Host of new products revealed in Ono Pharma's R&D pipeline
8 October 2001
New NICE guidance on Fludara in CLL; breast cancer advice on taxanes to
25 September 2001
Court frees 7 drugs from India's DPCO
3 September 2001
India to cut prices of 44 drug formulations
29 August 2001
Consumer groups sue S-P over Claritin claims
15 August 2001
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
